vTv Therapeutics (VTVT) Revenue (2014 - 2026)

vTv Therapeutics has disclosed Revenue across 11 years of filings, most recently posting $36.8 million for Q1 2026.

• In Q1 2026, Revenue changed N/A year-over-year to $36.8 million; the TTM figure through Jun 2026 stood at $36.8 million (up 216600.0% YoY), while the FY2024 annual figure was $1.0 million, changed N/A from the prior year.
• Revenue came in at $36.8 million for Q1 2026 at vTv Therapeutics, up from $17000.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $36.8 million in Q1 2026 to a low of $9000.0 in Q2 2022.
• Average Revenue over 3 years is $6.6 million, with a median of $508500.0 recorded in 2024.
• The largest YoY upside for Revenue was 102.63% in 2022 against a maximum downside of 0.0% in 2022.
• Over 3 years, Revenue stood at $9000.0 in 2022, then jumped by 88.89% to $17000.0 in 2024, then jumped by 216600.0% to $36.8 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $36.8 million in Q1 2026, $17000.0 in Q4 2024, and $1.0 million in Q1 2024.